Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eluxadoline for Diarrhea-Associated Fecal Incontinence
NCT03489265Phase 2Withdrawn
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of eluxadoline in fecal incontinence (FI), sponsored by University of North Carolina at Chapel Hill. Planned start Apr 2019; status: withdrawn.
02
Drugs
eluxadoline
03
Conditions
fecal incontinence (FI)
Beyond the preview
Go deeper on NCT03489265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03489265.